Drug-Coated Balloons in In-Stent Restenosis, a New Standard of Care or Yesterday's News?
作者信息
Weight Nicholas, Mamas Mamas A
机构信息
Keele Cardiovascular Research Group, Centre for Prognosis Research Institute for Primary Care and Health Sciences, Keele University Stoke-On-Trent United Kingdom.
National Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre Birmingham United Kingdom.
出版信息
J Am Heart Assoc. 2024 Dec 3;13(23):e038508. doi: 10.1161/JAHA.124.038508. Epub 2024 Nov 26.
Abstract
摘要
相似文献
1
Drug-Coated Balloons in In-Stent Restenosis, a New Standard of Care or Yesterday's News?药物涂层球囊治疗支架内再狭窄：是新的治疗标准还是明日黄花？
J Am Heart Assoc. 2024 Dec 3;13(23):e038508. doi: 10.1161/JAHA.124.038508. Epub 2024 Nov 26.
2
3
Drug-Coated Balloons Versus Drug-Eluting Stents or Plain Old Balloon Angioplasty: A Long-Term in-Stent Restenosis Study.药物涂层球囊与药物洗脱支架或普通球囊血管成形术：一项关于支架内再狭窄的长期研究
J Am Heart Assoc. 2024 Dec 3;13(23):e036839. doi: 10.1161/JAHA.124.036839. Epub 2024 Nov 22.
4
3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents.3 年 RIBS IV 临床试验临床随访：药物洗脱球囊与依维莫司洗脱支架治疗药物洗脱支架治疗后冠状动脉支架内再狭窄患者的前瞻性随机研究。
JACC Cardiovasc Interv. 2018 May 28;11(10):981-991. doi: 10.1016/j.jcin.2018.02.037.
5
Second-generation drug-eluting stents versus drug-coated balloons for the treatment of coronary in-stent restenosis: A systematic review and meta-analysis.第二代药物洗脱支架与药物涂层球囊治疗冠状动脉支架内再狭窄的系统评价和荟萃分析
Catheter Cardiovasc Interv. 2018 Aug 1;92(2):285-299. doi: 10.1002/ccd.27359. Epub 2017 Oct 10.
6
Percutaneous Coronary Intervention in the Elderly: Are Drug-coated Balloons the Future?老年患者的经皮冠状动脉介入治疗：药物涂层球囊会是未来的发展方向吗？
Curr Cardiol Rev. 2018 Mar 14;14(1):45-52. doi: 10.2174/1573403X14666171226144120.
7
Long-Term Results of Everolimus-Eluting Stents Versus Drug-Eluting Balloons in Patients With Bare-Metal In-Stent Restenosis: 3-Year Follow-Up of the RIBS V Clinical Trial.载药支架与药物球囊治疗金属裸支架内再狭窄的长期疗效：RIBS V 临床试验 3 年随访结果。
JACC Cardiovasc Interv. 2016 Jun 27;9(12):1246-1255. doi: 10.1016/j.jcin.2016.03.037. Epub 2016 Jun 20.
8
Comparative efficacy of drug-eluting balloon and drug-eluting stent for treatment of in-stent restenosis: a systematic review and meta-analysis.药物洗脱球囊与药物洗脱支架治疗支架内再狭窄的疗效比较：系统评价和荟萃分析。
J Pak Med Assoc. 2024 Jun;74(6 (Supple-6)):S51-S56. doi: 10.47391/JPMA.S6-ACSA-09.
9
Farewell to Drug-Eluting Balloons for In-Stent Restonsis?: Appropriate Technique of Drug-Eluting Balloons Implantation Matters.药物洗脱球囊用于支架内再狭窄的时代即将终结？药物洗脱球囊植入的合适技术至关重要。
JACC Cardiovasc Interv. 2018 May 28;11(10):992-994. doi: 10.1016/j.jcin.2018.04.002.
10
Long-Term Results of Bioresorbable Vascular Scaffolds in Patients With In-Stent Restenosis: The RIBS VI Study.生物可吸收血管支架治疗支架内再狭窄患者的长期结果：RIBS VI 研究。
JACC Cardiovasc Interv. 2024 Aug 12;17(15):1825-1836. doi: 10.1016/j.jcin.2024.05.038.
本文引用的文献
1
Drug-Coated Balloons Versus Drug-Eluting Stents or Plain Old Balloon Angioplasty: A Long-Term in-Stent Restenosis Study.药物涂层球囊与药物洗脱支架或普通球囊血管成形术：一项关于支架内再狭窄的长期研究
J Am Heart Assoc. 2024 Dec 3;13(23):e036839. doi: 10.1161/JAHA.124.036839. Epub 2024 Nov 22.
2
2024 ESC Guidelines for the management of chronic coronary syndromes.2024年欧洲心脏病学会慢性冠状动脉综合征管理指南
Eur Heart J. 2024 Sep 29;45(36):3415-3537. doi: 10.1093/eurheartj/ehae177.
3
Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trial.冠状动脉再狭窄治疗：普通球囊、药物涂层球囊与药物洗脱支架的比较——ISAR-DESIRE 3 试验 10 年随访结果
Eur Heart J. 2023 Apr 17;44(15):1343-1357. doi: 10.1093/eurheartj/ehad026.
4
Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent Restenosis.药物涂层球囊血管成形术与药物洗脱支架置入术治疗冠状动脉支架再狭窄患者的比较。
J Am Coll Cardiol. 2020 Jun 2;75(21):2664-2678. doi: 10.1016/j.jacc.2020.04.006.
5
Survival After Coronary Revascularization With Paclitaxel-Coated Balloons.紫杉醇涂层球囊冠状动脉血运重建术后的生存情况。
J Am Coll Cardiol. 2020 Mar 10;75(9):1017-1028. doi: 10.1016/j.jacc.2019.11.065.
6
Paclitaxel-coated balloon angioplasty vs. drug-eluting stenting for the treatment of coronary in-stent restenosis: a comprehensive, collaborative, individual patient data meta-analysis of 10 randomized clinical trials (DAEDALUS study).紫杉醇涂层球囊血管成形术与药物洗脱支架治疗冠状动脉支架内再狭窄的比较：10项随机临床试验的综合、协作、个体患者数据荟萃分析（代达罗斯研究）
Eur Heart J. 2020 Oct 7;41(38):3715-3728. doi: 10.1093/eurheartj/ehz594.
7
Treatment of Coronary Drug-Eluting Stent Restenosis by a Sirolimus- or Paclitaxel-Coated Balloon.药物涂层球囊治疗冠状动脉支架内再狭窄
JACC Cardiovasc Interv. 2019 Mar 25;12(6):558-566. doi: 10.1016/j.jcin.2018.11.040.
8
Drug-Eluting Balloons Versus Everolimus-Eluting Stents for In-Stent Restenosis: A Meta-Analysis of Randomized Trials.药物洗脱球囊与依维莫司洗脱支架治疗支架内再狭窄：一项随机试验的荟萃分析
Cardiovasc Revasc Med. 2019 Jul;20(7):612-618. doi: 10.1016/j.carrev.2018.08.010. Epub 2018 Aug 16.
9
Bioresorbable Scaffolds versus Metallic Stents in Routine PCI.生物可吸收支架与金属支架在常规 PCI 中的应用比较。
N Engl J Med. 2017 Jun 15;376(24):2319-2328. doi: 10.1056/NEJMoa1614954. Epub 2017 Mar 29.
10
Safety and Efficacy of Everolimus- Versus Sirolimus-Eluting Stents: 5-Year Results From SORT OUT IV.依维莫司洗脱支架与西罗莫司洗脱支架的安全性和疗效：SORT OUT IV 研究 5 年结果。
J Am Coll Cardiol. 2016 Feb 23;67(7):751-62. doi: 10.1016/j.jacc.2015.11.051.
Zotero 插件